Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial
Wang et al., The Lancet Regional Health - Western Pacific, doi:10.1016/j.lanwpc.2023.100835
https://c19early.org/wang23.html